158 related articles for article (PubMed ID: 7138618)
1. Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture.
Ishida T; Tanaka K
Atherosclerosis; 1982 Aug; 44(2):161-74. PubMed ID: 7138618
[TBL] [Abstract][Full Text] [Related]
2. Smooth muscle cell outgrowth stimulated by fibrin degradation products. The potential role of fibrin fragment E in restenosis and atherogenesis.
Naito M; Stirk CM; Smith EB; Thompson WD
Thromb Res; 2000 Apr; 98(2):165-74. PubMed ID: 10713318
[TBL] [Abstract][Full Text] [Related]
3. Effects of fibrinogen degradation products on glomerular mesangial cells in culture.
Tsumagari T; Tanaka K
Kidney Int; 1984 Nov; 26(5):712-8. PubMed ID: 6521256
[TBL] [Abstract][Full Text] [Related]
4. [Effects of fibrinogen, fibrin and their degradation products on the behaviour of vascular smooth muscle cells].
Naito M
Nihon Ronen Igakkai Zasshi; 2000 Jun; 37(6):458-63. PubMed ID: 10998926
[TBL] [Abstract][Full Text] [Related]
5. The enhanced activation of Glu-plasminogen by urokinase in the presence of fibrin or des A fibrin as measured by the release of B beta peptide and FDP.
Urano T; Takada Y; Takada A
Thromb Res; 1984 Dec; 36(5):429-35. PubMed ID: 6084324
[TBL] [Abstract][Full Text] [Related]
6. Activation of plasminogen by tissue activator is increased specifically in the presence of certain soluble fibrin(ogen) fragments.
Verheijen JH; Nieuwenhuizen W; Wijngaards G
Thromb Res; 1982 Aug; 27(4):377-85. PubMed ID: 6890721
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen and fibrinolysis in blood and in the arterial wall: its role in advanced atherosclerotic disease.
Martin-Paredero V; Vadillo J; Diaz J; Espinosa A; Berga C; Segura J; Sanchez J; Barbod A; Villaverde C; Richard CM
Cardiovasc Surg; 1998 Oct; 6(5):457-62. PubMed ID: 9794264
[TBL] [Abstract][Full Text] [Related]
8. Influence of fibrin, fibrinogen and fibrinogen degradation products on cultured endothelial cells.
Watanabe K; Tanaka K
Atherosclerosis; 1983 Jul; 48(1):57-70. PubMed ID: 6882509
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
Liu JN; Gurewich V
J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M
J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen/fibrin in atherogenesis.
Smith EB; Thompson WD; Crosbie L; Stirk CM
Eur J Epidemiol; 1992 May; 8 Suppl 1():83-7. PubMed ID: 1387095
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of inhibition of fibrinolysis and fibrinogenolysis by the end fibrinogen degradation products.
Khavkina LS; Rozenfeld MA; Leonova VB
Thromb Res; 1995 Apr; 78(2):173-87. PubMed ID: 7482434
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis and plasminogen concentration in aortic intima in relation to death following myocardial infarction.
Smith EB; Ashall C
Atherosclerosis; 1985 May; 55(2):171-86. PubMed ID: 4004989
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase deficiencies do not impair cell-associated fibrinolytic activity.
Ugwu F; Lemmens G; Collen D; Lijnen HR
Thromb Res; 2001 Apr; 102(1):61-9. PubMed ID: 11323016
[TBL] [Abstract][Full Text] [Related]
15. Fibrin deposition and fibrin degradation products in atherosclerotic plaques.
Smith EB
Thromb Res; 1994 Aug; 75(3):329-35. PubMed ID: 7992244
[TBL] [Abstract][Full Text] [Related]
16. Effects of pro-urokinase and urokinase on the fibrinolytic system in man.
Trübestein G; Popov S; Wolf H; Welzel D
Haemostasis; 1987; 17(4):238-44. PubMed ID: 2442078
[TBL] [Abstract][Full Text] [Related]
17. Effects of Ro 31-8220 on smooth muscle cell proliferation induced by fibrinogen degradation products.
Zhou B; Zhang JP; Hu ZL; Tao XB; Qian DH
Zhongguo Yao Li Xue Bao; 1997 Sep; 18(5):463-5. PubMed ID: 10322943
[TBL] [Abstract][Full Text] [Related]
18. The biosynthesis of fibrinogen: in vivo studies.
Bell WR
Ann N Y Acad Sci; 1983 Jun; 408():503-20. PubMed ID: 6575702
[No Abstract] [Full Text] [Related]
19. T-cell lymphokines, interleukin-4 and gamma interferon, modulate the induction of vascular smooth muscle cell tissue plasminogen activator and migration by serum and platelet-derived growth factor.
Wang W; Chen HJ; Giedd KN; Schwartz A; Cannon PJ; Rabbani LE
Circ Res; 1995 Dec; 77(6):1095-106. PubMed ID: 7586221
[TBL] [Abstract][Full Text] [Related]
20. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
